Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Fred Burke Sells 138,705 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider Fred Burke sold 138,705 shares of Guardian Pharmacy Services stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $2,796,292.80. Following the completion of the transaction, the insider now directly owns 413,019 shares in the company, valued at approximately $8,326,463.04. The trade was a 25.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Fred Burke also recently made the following trade(s):

• On Tuesday, May 27th, Fred Burke sold 747,102 shares of Guardian Pharmacy Services stock. The shares were sold at an average price of $20.16, for a total transaction of $15,061,576.32.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock traded down $0.10 during trading on Friday, reaching $21.29. The company's stock had a trading volume of 481,223 shares, compared to its average volume of 168,263. The business has a fifty day moving average price of $23.16 and a 200-day moving average price of $22.00. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to analyst estimates of $321.21 million. Equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on GRDN shares. Raymond James set a $28.00 price target on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a research note on Wednesday, May 14th. Truist Financial reissued a "buy" rating and issued a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Finally, Wall Street Zen lowered shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th.

Institutional Trading of Guardian Pharmacy Services

A number of institutional investors have recently made changes to their positions in GRDN. GAMMA Investing LLC acquired a new position in Guardian Pharmacy Services during the first quarter worth $170,000. R Squared Ltd acquired a new position in Guardian Pharmacy Services during the fourth quarter worth $30,000. BNP Paribas Financial Markets acquired a new position in Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc acquired a new position in Guardian Pharmacy Services during the fourth quarter worth $58,000. Finally, JPMorgan Chase & Co. acquired a new position in Guardian Pharmacy Services during the fourth quarter worth $77,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.